Bio-Medical Applications Of Texas, Inc. in Pasadena, Texas - Dialysis Center

Bio-Medical Applications Of Texas, Inc. is a medicare approved dialysis facility center in Pasadena, Texas and it has 13 dialysis stations. It is located in Harris county at 1210 Southmore Ave, Pasadena, TX, 77502. You can reach out to the office of Bio-Medical Applications Of Texas, Inc. at (713) 475-6617. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Texas, Inc. has the following ownership type - Profit. It was first certified by medicare in August, 2017. The medicare id for this facility is 452936 and it accepts patients under medicare ESRD program.

Name	Bio-Medical Applications Of Texas, Inc.
Location	1210 Southmore Ave, Pasadena, Texas
No. of Dialysis Stations	13
Medicare ID	452936
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of Texas, Inc. from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1497101463
Organization Name	Fresenius Medical Care Strawberry Park
Doing Business As	Bio-medical Applications Of Texas, Inc.
Address	1210 Southmore Ave Pasadena, Texas, 77502
Phone Number	(281) 421-4108

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	37
Patient months included in arterial venous fistula and catheter summaries	37
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	59
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	30